More reads
- More results being registered on ClinicalTrials.gov, but data quality is lacking, report finds. (STAT)
- At Trump’s demand, IPI proposal changed to get ‘best deal’ on Part B drugs. (BioCentury)
- Biotech-for-hire PeptiDream charts new path and becomes short target. (Reuters)
No hay comentarios:
Publicar un comentario